EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis

Sajid Khan, Sabahat Jamil, Muhammad Hamza, Zarlish Attique, Suping Zhang

Frontiers in Bioinformatics · 12.08.2026 · 6

DOI: 10.3389/fbinf.2026.1833416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 12.08.2026. Verfasst von Sajid Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Guangdong Key Laboratory for Genome Stability and Human Disease Prevent…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic breast cancer remains difficult to cure, and the way B and T lymphocytes adapt across metastatic niches especially under therapy remains insufficiently defined. Clarifying compartment specific immune remodeling may help explain resistance to PD-1/PD-L1 blockade and identify actionable targets. We performed an integrated meta-analysis of single cell RNA-seq datasets from normal breast tissue, primary tumors, tumor-draining lymph nodes (TLNs), and peripheral blood mononuclear cells (PBMCs), focusing on B and Tcell states. Immune composition differed notably by compartment. Tumors were enriched for effector CD8 states (CD8 cytotoxic 20.1%; CD8 activated 13.5%), whereas TLNs preserved larger naïve and memory reservoirs (CD4 naïve 40.7%; B naïve 11.4%; B memory 12.0%) and contained a higher B cell fraction than tumors (39.6% vs. 19.5%). Post therapy, PBMCs and TLNs showed increased BTLA-HVEM (TNFRSF14) checkpoint signaling and enhanced MIF-CD74 interactions with a shift from CD44 toward CXCR4, consistent with CXCR4 driven migratory and survival programs. In TLNs, TNFRSF14 signaling was unidirectional (B→T), absent in the reverse direction, and not detected in tumors. Clinically, higher tumor CXCR4 combined with lower TNFRSF14 was associated with shorter progression free survival in TCGA-BRCA, most evident in node positive, early stage disease. To target the BTLA-HVEM checkpoint axis, we performed structure guided de novo peptide design using the native HVEM (23-39) peptide as an active structural template, followed by docking and molecular dynamics simulations. The optimized De novo-P2 peptide showed stable and favorable interactions at the BTLA interface, supporting its potential as a competitive modulator of BTLA-HVEM signaling. These data define niche specific lymphocyte remodeling and implicate BTLA-HVEM and CXCL12-CXCR4 as candidate biomarkers and therapeutic targets linked to PD-1/PD-L1 resistance.

Schlagwörter

Stichwörter der Autor:innen

B&T cross talkScRNA-seqbreast cancerchemokine-cytokine signalinglymph node metastasis

Autor:innen und Institutionen

  • Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Department of Pharmacology, School of Basic Medical Science, Base…
  • Department of Bioinformatics, Government Postgraduate College Mandian, Abbottabad, Pakistan.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Khan, S., Jamil, S., Hamza, M., Attique, Z., & Zhang, S. (2026). Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1833416

Vancouver

Khan S, Jamil S, Hamza M, Attique Z, Zhang S. Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1833416

BibTeX
@article{Khan2026,
  author = {Khan, Sajid and Jamil, Sabahat and Hamza, Muhammad and Attique, Zarlish and Zhang, Suping},
  title = {Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis},
  journal = {Frontiers in Bioinformatics},
  year = {2026},
  volume = {6},
  doi = {10.3389/fbinf.2026.1833416}
}
Kostenlos starten →